PALB2 and ovarian cancer: However, after intensive treatment with ChT and radiotherapy, which she received for her B-ALL and TNBC and a known pathogenic variant in the PALB2 gene, her risk for the development of new primary cancers other than breast and ovarian cancers, particularly pancreatic cancer, may be substantial.